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APPL endosomes are a recently identiﬁed subpopula-
tion of early endosomes characterized by the presence
of two homologous Rab5 effector proteins APPL1 and
APPL2. They exhibit only limited colocalization with
EEA1, another Rab5 effector and a marker of the canoni-
cal early endosomes. Although APPL endosomes appear
to play important roles in cargo trafﬁcking and signal
transduction, their protein composition and biochemical
properties remain largely unknown. Here we employed
membrane fractionation methods to characterize APPL
endosomes biochemically. We demonstrate that they
represent heterogeneous membrane structures which
can be discriminated from the canonical EEA1-positive
early endosomes by their partly different physical prop-
erties and a distinct migration pattern in the continuous
density gradients. In search for other potential mark-
ers of APPL endosomes we identiﬁed Annexin A2 as an
interacting partner of both APPL1 and APPL2. Annexin
A2 is a Ca2+ and phosphatidylinositol 4,5-bisphosphate
binding protein, previously implicated in several endo-
cytic steps. We show that Annexin A2 co-fractionates
and colocalizes with APPL endosomes. Moreover, silenc-
ing of its expression causes solubilization of APPL2 from
endosomes. Although Annexin A2 is not an exclusive
marker of APPL endosomes, our data suggest that it has
an important function in membrane recruitment of APPL
proteins, acting in parallel to Rab5.
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Endocytosis involves internalization of macromolecules
from the cell surface into internal membrane compart-
ments (1). Various cargo molecules use different entry
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portals into cells which include well-characterized clathrin-
mediated endocytosis and other clathrin-independent
internalization pathways (2). Following uptake, cargo
molecules are sorted within the endosomal system and
follow one of the transport routes, resulting in recycling
to the plasma membrane, degradation in the lysosome or
retrieval to the Golgi apparatus.
Within the cell, one of the main cargo sorting stations
are early endosomes which harbor small GTPase Rab5
as their principal marker (3,4). Rab5 localizes also to
clathrin-coated vesicles (CCVs) and is a master regu-
lator of early steps of endocytosis (3). It operates via
a number of effector proteins which ensure tethering,
fusion and cytoskeleton-mediated motility of early endo-
somes (5–11).OneofthekeyRab5effectorsisearlyendo-
some antigen EEA1 (5,12). It localizes to the canonical
Rab5-positive early endosomes enriched in phosphatidyli-
nositol 3-phosphate [PI(3)P] and is considered a speciﬁc
marker for this compartment (13). However, in addition to
the canonical EEA1-positive endosomes, recent reports
demonstrated existence of Rab5-positive, PI(3)P-negative
early endosomes which harbor one or both homologous
adaptor proteins APPL1 and APPL2 (14–16). Like EEA1,
APPL proteins act as effectors of Rab5 and are recruited
to the endosomal membrane via interaction with an active
form of this GTPase (15). Both APPL proteins can form
homo- and heterodimers (17–20). APPL-positive mem-
brane structures, now termed APPL endosomes, show
only limited colocalization with EEA1 and are presently
considered a distinct subpopulation of early endosomes.
According to the current knowledge, both APPL proteins
localize to the same structures (15) and thus can be inter-
changeably used as markers of APPL endosomes. How-
ever, to date no other speciﬁc markers of this compart-
ment have been described. Moreover, APPL endosomes
are usually localized in cells more peripherally than the
canonical early endosomes, accumulating preferentially
underneath the plasma membrane (15). This localization
might reﬂect interactions between APPL endosomes and
the elements of the cell cortex such as actin ﬁlaments;
however, no such associations have been reported so far.
Thereisaccumulatingevidencesuggestingthat inaddition
to cargo trafﬁcking, endosomes play a pivotal role in intra-
cellular signal transduction. The canonical EEA1-positive
early endosomes are involved in signaling processes initi-
ated by various extracellular ligands (see Refs. 21–23 for
review). Signaling functions have also been demonstrated
for APPL endosomes which mediate Akt-dependent cell
survivalinzebraﬁshdevelopment (24)andactivationofAkt
and MAPK downstream of epidermal growth factor (EGF)
or nerve growth factor (NGF) in mammalian cells (25,26).
Moreover, APPL proteins themselves are involved in
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various signaling pathways, including signal transduction
downstream of adiponectin (27), follicle-stimulating hor-
mone (28), netrin-1 receptor DCC (29) or Wnt ligands (30).
These ﬁndings raise a possibility that a signaling role of
APPL endosomes extends into multiple pathways and
ligand–receptor systems which merits attempts to deﬁne
this compartment in more detail.
In this work we employed membrane fractionation meth-
ods to characterize APPL endosomes biochemically. In
search for other potential markers of APPL endosomes
we identiﬁed Annexin A2 as a protein co-fractionating
with this compartment and interacting with both APPL1
and APPL2. Importantly, Annexin A2 appears to mediate
APPL2 recruitment to the endosomal membranes which
represents a novel role of Annexin A2 within the endocytic
pathway.
Results
APPL endosomes are heterogeneous membrane
structures of various densities
To characterize the biochemical properties of APPL
endosomes we investigated their distribution in density
gradients in comparison to the canonical early endosomes
harboring EEA1 (hereinafter referred to as EEA1
endosomes). Density gradient ultracentrifugation of cellu-
lar lysates is commonly used for the isolation and charac-
terization of membrane-bound organelles. We decided to
use ﬂoatation gradients, as they are superior over the sedi-
mentationonesbecausemembranesisolatedbyﬂoatation
are free from cytoplasmic contaminants or aggregates
which can be present in membranes obtained by pellet-
ing.Inaclassicalmethodusedforinvitroendosomefusion
assays, functional populations enriched in either early or
late endosomes are isolated from a post-nuclear super-
natant (PNS) of cells by ﬂoatation during centrifugation in a
step gradient of sucrose (4,31,32). We chose this method
as a starting point and used PNS preparations from HeLa
cells grown in suspension for which scaled-up fractiona-
tion procedures to obtain large quantities of endosomal
material have been previously established (33). Using a
step sucrose gradient (35–25–8.5%; all concentrations
w/w), we could observe an enrichment of APPL1 pro-
tein in a fraction containing early endosomes as shown
by the presence of Rab5 and EEA1 (Figure 1A). Although
these results provided an independent demonstration that
APPL endosomes represent a fraction of early endoso-
mal compartments, no separation between APPL- and
EEA1 endosomes could be observed by this technique.
This was most likely because of insufﬁcient resolution
Figure 1: APPL endosomes are a heterogeneous population which exhibits a different fractionation pattern than the canonical
early endosomes in the continuous density gradients. PNSs extracted from S-HeLa cells were subjected to centrifugation in ﬂotation
gradients of sucrose (A and B) or OptiPrep (C). A) PNS sample adjusted to the ﬁnal sucrose concentration 40.6% (w/w) was loaded at
the bottom of a centrifuge tube and overlaid with step sucrose gradient (35, 25, 8.5%; all concentrations w/w). After centrifugation,
fractions enriched in early endosomes (ee) and late endosomes (le) were collected from 35–25 and 25–8.5% interphase, respectively,
and resolved on 10% SDS–PAGE followed by immunoblotting for EEA1, APPL1 and Rab5. Fractions from two independent gradients
of the same PNS sample are shown. B) PNS sample was adjusted to the ﬁnal sucrose concentration, 40.6% (w/w), and underloaded
at the bottom of a 10–40% (w/w) continuous sucrose gradient. After centrifugation, 16 fractions of equal volume (800 μL each) were
collected, pelleted, resolved on 10% SDS–PAGE and immunoblotted for EEA1, APPL1 and Rab5. C) PNS sample adjusted to the ﬁnal
OptiPrep concentration 40.6% (w/v) was underloaded at the bottom of a 5–20% (w/v) continuous OptiPrep gradient. Thirty-four fractions
of equal volume (350 μL each) were collected, pelleted, resolved on the gradient (6–15%) SDS–PAGE and immunoblotted for EEA1,
APPL1, Rab5 and AP50. In (A) and (B), 1.5 μL PNS (0.3% of the gradient input sample) was loaded as a control. In (C), 1 μL PNS (0.2%
of the gradient input sample) was loaded as a control. MW, lane with a molecular weight marker.
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of a step sucrose gradient. To improve the resolution
of endosome separation, we tested different ranges of
continuous sucrose gradients (5–30, 20–40, 10–40%, all
concentrations w/w; data not shown). The best resolution
was obtained using a 10–40% sucrose gradient (cor-
responding to the densities of 1.0381–1.1765 g/mL), in
which we could observe a partly distinct ﬂoatation pattern
of EEA1- and APPL endosomes, providing a ﬁrst indica-
tion for their non-identical physical properties (Figure 1B).
In contrast to EEA1 endosomes, APPL1-containing vesi-
cles exhibited a very broad migration through the whole
gradient, suggesting their heterogeneity. As expected for
an effector protein (APPL1) recruited to endosomes by a
GTPase (Rab5), all fractions harboring APPL1 were also
positive for Rab5.
To further improve the resolution of separation we
employed OptiPrep (iodixanol) as a gradient medium,
previously reported for the fractionation of endo-
somes (34–36). Its main advantage is low osmolarity
which can minimize artifacts of the isolation procedure, in
contrast to hyperosmolarity of concentrated sucrose solu-
tions that may affect the properties of membrane-bound
vesicles, e.g. causing their shrinking. Using a continuous
5–40% (w/v) OptiPrep ﬂoatation gradient (corresponding
to the densities of 1.032–1.215 g/mL) we were again able
to observe a broad migration pattern of APPL endosomes
ranging from high- to low-density fractions (Figure 1C).
Importantly, while high-density bottom fractions of the
gradient (fractions 1–10 of densities 1.215–1.114 g/mL)
contained both EEA1- and APPL endosomes, the latter
could ﬂoat to the fractions of much lower densities
than EEA1 endosomes. In particular, we observed high
accumulation of APPL endosomes in fractions 11–20
(densities 1.113–1.076 g/mL), with their traces present
also in fractions 25–26 (1.057–1.054 g/mL) and 32–34
(1.040–1.033 g/mL). Such a broad gradient distribution
points to a heterogeneous nature of APPL-harboring vesi-
cles which seem to include membrane structures of
different densities. At the same time, such biochemical
heterogeneity largely precludes efﬁcient isolation of frac-
tions enriched in APPL endosomes through separation
procedures based on physical properties such as den-
sity gradient centrifugation. Moreover, the migration of
APPL endosomes was clearly distinct from that of CCVs
characterized by the presence of the AP50 protein (AP-2
complex subunit μ) (37) (Figure 1C). Again, Rab5-positive
vesicles were broadly distributed throughout all gradient
fractions, consistent with the fact that several early endo-
cytic structures (EEA1 endosomes, APPL endosomes,
CCVs) are marked by this GTPase. Overall, the fraction-
ation studies indicate that APPL endosomes represent
a biochemically heterogeneous population, consisting of
membrane structures of different densities. These data
are in agreement with previous electron microscopy stud-
ies, documenting the presence of APPL1 on membrane
proﬁles of various sizes and shapes (small vesicles, vac-
uoles or tubules) (15).
Annexin A2 co-migrates with APPL endosomes
on density gradients
ToidentifyanyfurtherconstituentsresidingonAPPLendo-
somes, we attempted to establish an immunoisolation
procedure for proteins bound to APPL1 on endosomes.
However, APPL proteins are only peripherally associated
with the endosomal membranes via active GTP-bound
Rab5 molecules (15) and thus dissociate easily, particu-
larly in cell lysates. Therefore, we employed chemical
cross-linking using a cleavable, sulfhydryl-reactive homo-
bifunctional cross-linker DPDPB to stabilize binding of
proteins to the membranes (either in PNS or in gradi-
ent fractions enriched in early endosomes from HeLa
cells) before the immunoisolation procedure. Such stabi-
lized preparations were applied to Protein G Agarose with
covalently bound anti-APPL1 antibodies or control rabbit
immunoglobulin G (IgG). After washing and eluting, the
resulting eluates were subjected to mass spectrometry
sequencing. Although the efﬁciency of the procedure was
low, we repeatedly identiﬁed Annexin A2 and the APPL1
protein itself in samples isolated on the anti-APPL1 col-
umn. Annexin A2 was the only protein reproducibly found
in the immunoisolates obtained from both types of the
starting material (PNS and endosome-enriched fractions).
Annexin A2 is known to exhibit a broad distribution
among endocytic compartments, including early endo-
somes (38–40), and therefore could not represent an
exclusive marker of APPL endosomes. However, among
its various functions, Annexin A2 is an important media-
tor of the interaction between endosomes and the actin
cytoskeleton (38,39,41,42), and for this reason we found
its possible association with APPL endosomes of partic-
ular interest. We therefore investigated the distribution
of Annexin A2 in membrane fractions resulting from the
centrifugation in an OptiPrep density gradient. Similar to
APPL2, Annexin A2 exhibited a broad migration ranging
from high- to low-density fractions (Figure 2A). Quantita-
tive analysis of the gradient fractions by immunoblotting
and infrared imaging demonstrated a complex distribu-
tion pattern, including a few local accumulation peaks,
which was very similar for both APPL2 and Annexin A2
(Figure 2B). These data indicate that both proteins may
be present on the same membrane structures. To test
this concept, we investigated the localization of both
proteins by immunoﬂuorescence microscopy. Using a
standard procedure of cell ﬁxation followed by perme-
abilization, we could not unequivocally demonstrate a
direct colocalization of APPL proteins and Annexin A2 on
vesicles because of the strong cytoplasmic staining of
Annexin A2 (Figure 2C). Nevertheless, even under such
conditions, APPL endosomes were clearly surrounded by
Annexin A2 staining or in apparent contact with Annexin-
positive ﬁbrous structures. To reduce cytoplasmic staining
of Annexin A2, cells were ﬁrst permeabilized before ﬁxa-
tionandinthiscasewecouldobserveaclearcolocalization
of APPL2-positive endosomes with Annexin A2-labeled ﬁl-
amentous structures (Figure 2D). These data argue that at
least some Annexin A2 colocalizes with APPL2.
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Figure 2: Annexin A2 and APPL2 show a highly similar migration pattern in a continuous OptiPrep gradient and colocalize with
each other in cells. A) PNS extracted from S-HeLa cells was adjusted to the ﬁnal OptiPrep concentration, 40.6% (w/v), and underloaded
at the bottom of a 5–20% (w/v) continuous OptiPrep gradient. After centrifugation, 27 fractions of equal volume (450 μL each) were
collected, pelleted, resolved on the gradient (6–15%) SDS–PAGE and immunoblotted for APPL2 and Annexin A2. B) Western blot
shown in A was subjected to densitometric analysis with Odyssey Infrared Imaging System. Fluorescence intensities of APPL2 and
Annexin A2 bands in each fraction are expressed in arbitrary units (AU). C and D) Colocalization analysis of APPL2 and Annexin A2 in
CCD-1070SK cells. In (C), cells were ﬁxed, permeabilized and immunostained with antibodies against APPL2 (red) and Annexin A2 (HH7
clone; green). In (D), cells were initially permeabilized as described in Materials and Methods in order to wash away the cytoplasmic
fraction of Annexin A2, then ﬁxed and immunostained as in D. Single confocal sections are shown in (C) and (D). Scale bar, 20 μm.
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Annexin A2 interacts with APPL1 and APPL2
As Annexin A2 was a major protein present in APPL1
immunoisolates and co-migrated with APPL2 on density
gradients, we further tested whether APPL proteins
and Annexin A2 could interact. Therefore, we analyzed
APPL-binding proteins using an in vivo biotinylation and
afﬁnity puriﬁcation procedure. HEK293 cells were co-
transfected with two vectors, one encoding a bacterial
biotin ligase BirA and the other harboring APPL1 or APPL2
tagged with a BirA target sequence which undergoes
biotinylation in vivo (43). Biotinylated green ﬂuorescent
protein (GFP) served as a speciﬁcity control. Proteins
bound to biotinylated APPL1, APPL2 or GFP were isolated
with streptavidine-conjugated beads and analyzed for the
presence of Annexin A2 by western blotting. Strikingly,
Annexin A2 was clearly retained on the beads containing
either APPL1 or APPL2, the latter binding seemingly
more Annexin A2 (Figure 3A). No association of Annexin
A2 with control biotinylated GFP was detected. The
presence of Annexin A2-derived peptides among APPL1-
or APPL2-bound proteins was additionally conﬁrmed by
mass spectrometry analysis (data not shown). To test the
speciﬁcity of Annexin A2 binding, we also tested other
Annexins implicated in various endocytic steps, such
as A1 and A6 (44). No interactions of Annexins A1 or
A6 with APPL proteins could be detected by the same
afﬁnity puriﬁcation procedure using biotinylated APPL1
or APPL2 (Figure 3B). Consistently, probing OptiPrep
density gradient fractions for Annexins A1 and A6
revealed that both proteins were absent in the light
gradient fractions enriched in Annexin A2 and APPL2
(Figure 3C).
To verify the interaction with APPL proteins by an indepen-
dent method, glutathione S-transferase (GST)–Annexin
A2 fusion protein was puriﬁed and used as a bait in a
pull-down experiment with HEK293 cell lysates derived
from cells overexpressing HA-APPL1 or HA-APPL2. As
shown in Figure 3D,E, both APPL proteins were retained
on GST–Annexin A2 beads, indicating that both APPL1
and APPL2 share the ability to interact with Annexin A2.
To address the question of whether these interactions are
direct, we performed an additional pull-down experiment
using in vitro translated APPL2 instead of cell lysates. The
results presented in Figure 3F demonstrate that APPL2
binds to the Annexin A2 in a direct manner. Although we
could not convincingly show such direct binding for in
vitro translated APPL1 because of its strong background
binding to the beads, it is very likely that APPL1 also
directly associates with Annexin A2 (particularly as we
initially identiﬁed Annexin A2 in APPL1 immunoisolates,
see above).
Finally, in order to obtain more insight into the
nature of Annexin A2–APPL interactions, we tested
several previously characterized Annexin A2 mutants
for binding to APPL2 (Figure 3G). The following ﬁve
mutants were expressed as GST fusion proteins: ‘total
Ca2+minus’ [TCM; unable to bind calcium ions because
of point mutations in type II and type III Ca2+-binding
sites; (45)], two point mutants in Tyr23 residue which
upon phosphorylation mediates binding of Annexin A2 to
endosomes (46) [phosphorylation-deﬁcient Y23A mutant
which is not recruited to endosomes in vivo,a n da
phosphomimetic Y23D mutant capable of endosome
binding which in addition affects actin dynamics in the
cell (47)] and two C-terminal truncations of 9 or 13
amino acids (CT9o rC T 13, respectively), unable to
associate with F-actin (48). All of the tested mutants
were able to interact with APPL2 in a GST pull down
(Figure 3G). This indicates that the residues of Annexin A2
critical for binding calcium, endosomes or F-actin are not
involved in its association with APPL2. It is therefore
likely that these binding sites are independent and
non-overlapping.
Annexin A2 is essential for targeting APPL2
to endosomes and can compensate for Rab5
deﬁciency in mediating APPL membrane recruitment
We wished to determine the functional importance of
APPL–Annexin A2 interaction and hypothesized that
it may be important for the morphology or cellular
localization of APPL endosomes. To investigate this
question, we chose human ﬁbroblast cells CCD-1070SK
which endogenously express high levels of Annexin
A2 and APPL2, the latter used as a marker of
APPL endosomes. We set out to test the effects
of reduced Annexin A2 levels on APPL endosomes.
Three independent siRNA duplexes were used to very
efﬁciently silence the expression of Annexin A2 in CCD-
1070SK ﬁbroblasts, as shown in Figure 4A. Strikingly,
when analyzed by confocal microscopy, these cells
exhibited much lower staining of APPL2, as compared
to cells transfected with control siRNAs (Figure 4B). All
three duplexes targeting Annexin A2 showed similar
effects. To quantify the observed changes, we employed
image analysis software MOTIONTRACKING a sap r o v e n
tool for measuring quantitative differences in parameters
of objects detected by ﬂuorescence microscopy (49,50).
Such analysis demonstrated that the overall ﬂuorescence
of APPL2 detected in vesicular structures, categorized
by the software as endosomes, is greatly reduced by
AnnexinA2silencing(Figure 4C),althoughthetotalAPPL2
levels in the cells remain unchanged (Figure 4A). These
data indicate that APPL2 protein is displaced from the
endosomal membranes and its cytoplasmic pool is likely
in part removed during the immunostaining procedure and
too disperse to be efﬁciently visualized. Consequently,
because of the reduced membrane staining of APPL2, the
number of detectable APPL endosomes is also decreased
upon Annexin A2 knockdown (Figure 4D). These changes
were speciﬁc for APPL2, as no solubilization of other
endosomal markers such as EEA1, Rab5 or Rab11 was
observed upon depletion of Annexin A2 (Figure 4E,F).
Thus, our results allow concluding that the direct
interaction between Annexin A2 and APPL2 appears to
be required for the recruitment of APPL2 protein to the
membrane of APPL endosomes.
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Annexin A2 is a calcium-binding protein which interacts
speciﬁcally with phosphatidylinositol 4,5-bisphosphate
[PI(4,5)P2] (45,51–53). To get further insight into Annexin
A2-mediated endosomal recruitment of APPL2 we
checked whether reducing the availability of PI(4,5)P2 or
alteringcytoplasmiccalcium levelscouldaffectmembrane
association of APPL2. To the ﬁrst end, we overexpressed
the PH domain of phospholipase Cδ (PH-PLC) which
Figure 3: Legend on next page.
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speciﬁcally binds to PI(4,5)P2 and at high levels should
outcompete other PI(4,5)P2-binding proteins (54). Under
these conditions, we observed a solubilization of APPL2
from endosomes (Figure 5A) which argues that PI(4,5)P2
levels are important for membrane association of
APPL2. In contrast, increasing the cytoplasmic calcium
concentration by ionomycin treatment did not affect
an endosomal localization of APPL2 (Figure 5B). The
efﬁciency of ionomycin action was controlled by observing
calcium-induced clustering of Ca2+-binding C2 domain of
protein kinase Cγ fused to GFP [C2-PKC] (55).
Finally, we tested whether Annexin A2 co-operates
with Rab5 in mediating membrane association of APPL
proteins. Active Rab5 in a GTP-bound form is known to
recruit APPL proteins to endosomes, while a GDP-locked,
dominant-negative mutant Rab5-S34N solubilizes them
from the membranes (15). We therefore checked the
distribution of APPL2 upon overexpression of Annexin A2
in the presence of Rab5-S34N. Interestingly, high levels of
Annexin A2 prevented loss of APPL2 from the endosomes
caused by the Rab5 mutant (Figure 6). These data argue
that Annexin A2 acts independently of Rab5 and can at
least partly compensate for Rab5 deﬁciency in mediating
membrane association of APPL proteins. Cumulatively,
these results indicate that the presence of APPL proteins
on endosomes is determined by at least two factors, such
as active Rab5 and the levels of Annexin A2.
Discussion
APPL endosomes were originally described in 2004,
based mainly on light- and electron microscopy data
which demonstrated signiﬁcant segregation between
APPL1 and a marker of canonical early endosomes,
EEA1 (15). To date, only two speciﬁc markers of APPL
endosomes are known, being APPL1 and APPL2 (of
which often one is predominantly expressed in a given
cell type; our unpublished observations). Rab5, which
binds APPL proteins on APPL endosomes, also resides
on other endocytic structures, such as the canonical
EEA1 endosomes and CCVs, therefore cannot serve as
a speciﬁc marker. In general, no biochemical studies of
APPL endosomes have been undertaken and no other
resident proteins reported.
Our studies employing various fractionation techniques
demonstrate that (i) in step sucrose gradients APPL
endosomes behave as early endosomes, as they partition
with this compartment but not with late endosomes,
and that (ii) APPL endosomes can be discriminated from
the canonical EEA1-positive early endosomes by their
partly different physical properties and a distinct migration
pattern in continuous density gradients. Moreover, in
contrast to the canonical EEA1-positive endosomes which
appeartobemuchmorehomogeneous,APPLendosomes
are biochemically heterogeneous and segregate into
multiple gradient fractions of various densities. These
results conﬁrm the initial electron microscopy studies
describing variable size and morphology of APPL-labeled
membrane structures (15) although the molecular basis
for such diversity of APPL endosomes remains unknown.
One of the main difﬁculties with detailed characterization
of APPL endosomes, using either biochemical or
microscopy methods, is lack of speciﬁc transmembrane
markers. APPL proteins are both cytosolic and peripherally
bound to the membranes (similar to Rab5). Any treatment
causing solubilization of APPL proteins makes APPL
endosomes impossible to distinguish from other Rab5-
positive early endosomes. Therefore, it is so far
not feasible to determine whether silencing of APPL
proteins affects the functionality of the compartment.
Similarly, while inhibition of clathrin-mediated endocytosis
was shown to reduce the endosomal localization of
APPL1 and was interpreted as the loss of APPL
endosomes (16), it cannot be formally excluded that only
membrane recruitment of APPL1 was abolished under
such conditions, while the compartment per se was
preserved. In our search for further markers of APPL
endosomes, we attempted to circumvent the problem
Figure 3: Annexin A2, but not Annexins A1 or A6, interacts with APPL proteins. A and B) HEK293 cells were co-transfected with
the plasmid encoding bacterial biotin-protein ligase (BirA) and one of the plasmids encoding GFP, APPL2 or APPL1 tagged with a BirA
target sequence (pBT-GFP, pBT-APPL2, pBT-mycAPPL2 or pBT-mycAPPL1). Forty-eight hours after transfection, cells were lysed and
afﬁnity puriﬁcation of APPL-interacting proteins was performed with streptavidine-conjugated magnetic beads. A) Binding of Annexin A2
to in vivo biotinylated APPL1 or APPL2 proteins is shown. Samples were resolved on 10% SDS–PAGE. Nitrocellulose membrane was
stained with Ponceau S (lower panel) and immunoblotted for Annexin A2 (upper panel). B) Binding of Annexin A1 and Annexin A6 to in
vivo biotinylated APPL1 or APPL2 proteins was tested. Samples were resolved on 10% SDS–PAGE and immunoblotted for Annexin A1
and Annexin A6, with Annexin A2 serving as a positive control. C) Migration of Annexins A1 and A6 in the OptiPrep density gradient.
PNS sample adjusted to the ﬁnal OptiPrep concentration 40.6% (w/v) was underloaded at the bottom of a 5–20% (w/v) continuous
OptiPrep gradient. Twenty-ﬁve fractions of equal volume (500 μL each) were collected, pelleted, resolved on the gradient (6–15%)
SDS–PAGE and immunoblotted for APPL2, Annexin A6, Annexin A1 and Annexin A2. D–F) GST pull-downs were performed with
wild-type GST–Annexin A2 (GST–ANXA2) or GST alone with lysates from HEK293 cells overexpressing HA-APPL1 (D) and HA-APPL2
(E) or in vitro translated APPL2 (F). All samples were resolved on 8% SDS–PAGE and immunoblotted for APPL1 or APPL2, as indicated.
As controls, 1 μL of cell lysates (1% of the input) was loaded in (D) and (E), and 1 μL in vitro translated protein (2% of the input) was
loaded in F. G) GST pull-downs were performed with GST–Annexin A2 wild-type (GST–ANXA2) or mutants (TCM, Y23D, Y23A, CT9,
CT13), or GST alone using lysates from HEK293 cells overexpressing HA-APPL2. All samples were resolved on 10% SDS–PAGE.
Nitrocellulose membrane was stained with Ponceau S (lower panel) and immunoblotted for APPL2 (upper panel). As a control, 1 μLo f
cell lysate (1% of the input) was loaded. MW, lane with a molecular weight marker.
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Figure 4: Annexin A2 knockdown causes solubilization of APPL2 from endosomes. A–D) CCD-1070SK cells were transfected
with three different siRNAs targeting Annexin A2 (AnxA2 siRNA_1-3) or two non-targeting negative controls (nc1, nc2), or were mock
transfected (nt). A) Ninety-six hours after transfection, cells were lysed and the level of Annexin A2 was assessed. Samples were
resolved on 8% SDS–PAGE and immunoblotted for APPL2 and Annexin A2, with β-actin as a loading control. B) Cells were ﬁxed and
immunostained with antibodies against APPL2. Single confocal images are shown. Scale bar, 20 μm. C and D) Total integral ﬂuorescence
intensity of APPL2 vesicles (C) and their average number (D) were quantiﬁed using MOTIONTRACKING software. At least 20 images of each
variant were subjected to the analysis. The data are representative of three independent experiments. Error bars are SEM (standard error
of the mean), ﬂuorescence intensity is expressed in arbitrary units (AU). E and F) CCD-1070SK cells were transfected with non-targeting
negative siRNA control nc2 (E) or with siRNA AnxA2 siRNA_3 targeting Annexin A2 (F), ﬁxed and immunostained with antibodies against
Annexin A2 and endosomal markers EEA1, Rab5 or Rab11, as indicated. Scale bar, 20 μm.
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Figure 4: Continued.
of APPL protein release by chemical cross-linking of
either isolated membrane fractions or PNS before APPL1
immunoprecipitation. Although we failed to identify any
transmembrane marker proteins, these experiments led
to the identiﬁcation of Annexin A2 as a component of
APPL endosomes. While Annexin A2 is not an exclusive
marker of APPL endosomes, it appears to interact with
APPL proteins and regulate their membrane recruitment
along with active Rab5. Importantly, high levels of Annexin
A2 are sufﬁcient to ensure membrane association of
APPL2 even in the presence of inactive Rab5 mutant
which alone causes dissociation of APPL proteins from
endosomes. The fact that APPL membrane recruitment
depends on two factors, active Rab5 and Annexin A2,
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Figure 5: PI(4,5)P2 availability but not increased calcium concentration affects APPL2 localization to endosomes. A) CCD-1070SK
cells were transfected with the plasmid encoding the PH domain from PLCδ1 fused to GFP (PH-PLC) which speciﬁcally binds PI(4,5)P2.
Cells were immunostained with antibodies against APPL2 (red) and GFP (green). Single confocal sections are shown. Scale bar, 35 μm.
B) CCD-1070SK cells were transfected with the plasmid encoding the C2 domain from PKCγ fused to GFP (C2-PKC) which serves as an
indicator of increased cytoplasmic calcium levels. Twenty-four hours upon transfection, cells were treated with 1 μM ionomycin (lower
panel) for 1 min or left untreated (upper panel). Subsequently cells were ﬁxed and immunostained with antibodies against APPL2 (red)
and GFP (green). Single confocal sections are shown. Scale bar, 25 μm.
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Figure 6: Overexpression of Annexin A2–GFP rescues the endosomal localization of APPL2 in cells transfected with the
dominant-negative Rab5-S34N mutant. CCD-1070SK cells were transfected with plasmids encoding Annexin A2–GFP, myc-tagged
Rab5-S34N or both, as indicated. Cells were ﬁxed and immunostained with antibodies against APPL2 (green), GFP (red) and myc (blue).
Single confocal sections are shown. Scale bar, 20 μm.
is reminiscent of another Rab5 effector, EEA1 whose
membrane localization is determined by the presence of
active Rab5 and PI(3)P on endosomes. These two factors
can also partly compensate for each other in recruiting
EEA1 to early endosomes (6), similar to Rab5 and Annexin
A2 in the case of APPL proteins.
Annexin A2 belongs to the annexin family of calcium- and
phospholipid-binding proteins which exhibit a multitude
of functions related to the organization and dynamics of
membrane organelles (56). Among other compartments,
Annexin A2 localizes to early endosomes and regulates
their spatial distribution (38,39). Binding of Annexin A2
to early endosomes depends on cholesterol but is
independent of calcium or p11/S100A10 ligand (46,57,58).
Moreover, Annexin A2 directly interacts with actin
ﬁlaments in a calcium-dependent manner (59) and binds
to PI(4,5)P2 (51–53). It regulates the formation of actin
comets propelling macropinosomes (60) and is crucial
for the nucleation of actin patches on early endosomes
which are required for membrane remodeling during cargo
transport toward late endosomes (42). It is thus tempting
to speculate that Annexin A2 could link APPL endosomes
to the actin cytoskeleton. Unfortunately, loss of APPL
from the endosomal membranes upon knockdown of
Annexin A2 precludes a direct test of such a hypothesis,
as under these conditions APPL endosomes become
largely undetectable. In many cell lines APPL endosomes
are localized underneath the plasma membrane and more
peripherally than the canonical early endosomes but the
mechanisms of their anchoring to the cell cortex are not
clear. Annexin A2 is known to govern the intracellular
distribution of the canonical early endosomes (39) and it
could have a similar function for APPL endosomes.
Finally, it has been shown that in ﬁbroblasts of Lowe
syndrome patients, Annexin A2 accumulates on actin
comet tails which are constitutively formed on intra-
cellular vesicles because of the increased levels of
cellular PI(4,5)P2 (61). This disease is caused by muta-
tions in oculocerebrorenal syndrome of Lowe (OCRL),
inositol 5-phosphatase (62) which preferentially acts on
PI(4,5)P2 and phosphatidylinositol 3,4,5-trisphosphate
[PI(3,4,5)P3]. Intriguingly, APPL1 is known to bind directly
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to OCRL (14,63,64). As Annexin A2 binds PI(4,5)P2, which
is dephosphorylated by OCRL, it may suggest that the
associations of APPL1 with Annexin A2 and with OCRL
are mutually exclusive. Moreover, it may imply a temporal
regulation of these interactions, where APPL binding to
Annexin A2 would be important for the initial membrane
recruitment of APPL and precede its association with
OCRL which would lead to the local depletion of PI(4,5)P2
and thus Annexin A2 release. Although APPL2 does not
bind OCRL directly (14), its indirect association with OCRL
via heterodimers with APPL1 cannot be excluded.
In summary, in this work we characterized APPL
endosomes as a biochemically discernible subpopulation
of early endosomes and identiﬁed Annexin A2 as one
of its components. Importantly, Annexin A2 appears to
be required for endosomal localization of APPL2, acting
along with Rab5. These data add yet another role to
the spectrum of endocytic functions of Annexin A2, as a
determinant of APPL membrane recruitment.
Materials and Methods
Cell culture and transfection
S-HeLa cells were grown in suspension in S-MEM (Spinner Modiﬁcation of
Minimum Essential Medium Eagle) supplemented with 10% newborn calf
serum,2 mML-glutamine,MEMNon-essentialAminoAcidSolution(Sigma-
Aldrich), 100 U/mL penicillin and 100 μg/mL streptomycin. CCD-1070SK
and HEK293 cells were grown in MEM and DMEM, respectively, both
supplemented with 10% fetal calf serum, 2 mML -glutamine, 100 U/mL
penicillin and 100 μg/mL streptomycin under 5% CO2. For transfection
of plasmids Lipofectamine-2000 (Invitrogen) was used according to the
manufacturer’s instructions. Ionomycin (Sigma-Aldrich) was used at 1 μm
concentration.
Antibodies and western blot quantitative analysis
Polyclonal antibodies against APPL1, APPL2 and EEA1 were previously
described (15,30). Mouse anti-Annexin A2 clone HH7 (40) was a kind gift
fromDr.V.Gerke.Thefollowingantibodieswereobtainedfromcommercial
sources: anti-Rab5 (Abcam); anti-Rab11 (Invitrogen); anti-β-actin (Sigma);
anti-Annexin A2, anti-Annexin A1, anti-Annexin A6, anti-AP50 and anti-
EEA1 (BD Biosciences); anti-myc (clone 9E10 from Abcam). Goat antibody
against GFP was obtained from MPI Dresden. Horseradish peroxidase
(HRP)-conjugated anti-mouse and anti-rabbit antibodies were from Jackson
ImmunoResearch; Alexa 488-, 555- or 647-conjugated anti-mouse, anti-
rabbit or anti-goat secondary antibodies were from Invitrogen; IRDye
800CW donkey anti-mouse and IRDye 680LT donkey anti-rabbit antibodies
from LI-COR Biosciences. Fluorescence quantitative analyses of western
blots were performed with Odyssey Infrared Imaging System 3.0 (Li-COR
Biosciences).
Plasmids
To obtain pGEX-AnnexinA2, Annexin A2 open reading frame (ORF) (clone
IRALp962P0840Q obtained from www.imagenes-bio.de) was subcloned
to pGEX-6P-1 (GE Healthcare), using the following primers: forward TACG-
GATCCTCTACTGTTCAC, reverse TACCTCGAGTCAGTCATCTCC. Single-
point mutations were introduced into pGEX-AnnexinA2 using QuikChange
site-directed mutagenesis (Stratagene) to generate the following mutants:
Y23D, Y23A (46), CT9o rC T 13 (48). Annexin A2 TCM mutant was sub-
cloned to pGEX-6P-1 from pDS10-AII-TCM received from Dr. V. Gerke (45).
Plasmids pcDNA3.1-APPL2, pcDNA3-HA-APPL1 and pcDNA3-HA-APPL2
were previously described (15,30). Plasmids for expression of BirA and
of biotinylated GFP (pBT-GFP) were a kind gift of Dr. C. Hoogenraad.
To obtain plasmids for expression of biotinylated APPL2 and myc-
APPL1 (pBT-APPL2, pBT-mycAPPL1), the following pairs of primers
were used for subcloning into pBT: APPL2 forward GTCGTCGACATGG
AGCAGAAGCTGATCTCCGAGG and reverse GCGGGCGGCCGCTTATG
CTTCTGATTCTCTCTTC; APPL1 forward GTCGTCGACATGCCCGCCGT
GGACAAGCTCCTGC and reverse CCGCGCGGCCGCTTATGCTTCGGATTC
TGCGCCTC. The plasmid GFP-pcDNA3-PKCgamma-C2 was provided
by Dr. Tobias Meyer (Addgene plasmid 21215) (55). The plasmid en-
coding the PH-PLC was previously described (65).
Preparation of PNS
S-HeLa cells were grown at the density of 106 cells/mL in a spinner ﬂask
in a total volume of 2.4 L. Cells were brieﬂy centrifuged, and washed three
times with PBS, followed by two washes in SIM buffer (250 mM sucrose,
3m M imidazole, 1 mM MgCl2 pH 7.4). Cell pellets were resuspended in
2 volumes of SIM buffer with 1 mM DTT and protease inhibitors. Cells
were broken by 10 passages through an ice-cold ball-bearing homogenizer
(EMBLHeidelberg)witha16-μmclearance.Theresultingcellhomogenates
were spun for 20 min at 2000 × g at 4◦C. Supernatant (PNS) was collected
for further analysis.
Fractionation of endosomes by ultracentrifugation
in density gradients
Endosome fractionation on a step sucrose gradient was conducted
essentially as previously described (66). In brief, PNS was adjusted to
40.6% (w/w) sucrose by mixing with 62% (w/w) sucrose solution and
1.1 mL of such mix was loaded at the bottom of 13.2 mL ultracentrifuge
tube. It was overlaid with 4 mL 35% (w/w) sucrose in 3 mM imidazole
pH 7.4, 4 mL 25% sucrose (w/w) in 3 mM imidazole pH 7.4 and the tube
was ﬁlled with SIM buffer [8.5% (w/w) sucrose]. The loaded gradient was
centrifuged in an SW 41 Ti rotor (Beckmann Coulter) at 100 000 × g for 6 h
at 4◦C. Early endosome fraction was collected with the peristaltic pump
from the 25–35% interphase and the late endosome one from the 25%
SIM interphase.
The continuous 10–40% sucrose gradient was made using a Gradient
Master (BioComp Instruments, Inc.). The gradient was prepared freshly
in a 13.2 mL tube. PNS was adjusted to 40.6% (w/w) sucrose by mixing
with 62% sucrose solution and 1.1 mL of such mix was underloaded at
the bottom of the gradient. The loaded gradient was centrifuged in an
SW 41 Ti rotor at 100 000 × g for 6 h at 4◦C. After ultracentrifugation,
16 fractions of equal volume (800 μL) were collected with the peristaltic
pump, diluted in ice-cold PBS and pelleted by centrifugation (110 000
× g for 45 min), resolved on 10% SDS–PAGE and immunoblotted for
the proteins of interest. The linearity of gradients was checked with a
refractometer.
OptiPrep gradients were prepared from a ready-made solution of 60%
iodixanol (w/v) in water, commercially available under the name of OptiPrep
(Axis-Shield; density: 1.32 ± 0.001 g/mL; osmolarity: 170 ± 15 mOsm). The
working iodixanol solutions (5 and 20%, w/v) for gradients were prepared
by two subsequent dilution steps as follows. First, to prepare a 40%
(w/v) solution, 2 volumes of 60% iodixanol were mixed with 1 volume of
the OptiPrep dilution buffer (235 mM KCl, 12 mM MgCl2,2 5m M CaCl2,
30 mM EGTA, 150 mM HEPES–NaOH pH 7.0). Second, to obtain 5 and
20% solutions, 40% iodixanol (w/v) was diluted with the working solution
dilution buffer (78 mM KCl, 4 mM MgCl2,8 . 4 m M CaCl2,1 0 m M EGTA,
50 mM HEPES–NaOH pH 7.0).
The continuous 5–40% OptiPrep gradient was prepared freshly in a
13.2 mL tube. PNS was adjusted to 40.6% (w/v) OptiPrep by mixing
with 60% OptiPrep and 1.1 mL of such mix was underloaded at the
bottom of 5–20% gradient pre-made using a Gradient Master. The loaded
gradient was centrifuged in an SW 41 Ti rotor at 100 000 × g for 20 h at
4◦C. After ultracentrifugation, fractions of equal volume were collected,
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diluted in ice-cold PBS and precipitated by centrifugation (at 110 000 × g
for 45 min), resolved on SDS–PAGE and immunoblotted for the proteins
of interest. The linearity of gradients was checked with a refractometer.
Early endosome-enriched fraction, as a starting material for immunoiso-
lation, was obtained from the OptiPrep step gradient (40–18–5%). PNS
was adjusted to 40% (w/v) OptiPrep by mixing with 60% (w/v) OptiPrep
solution, and 1.1 mL of such mix was loaded at the bottom of 13.2 mL
ultracentrifuge tube. It was overlaid with 8 mL 18% (w/v) OptiPrep, and
the tube was ﬁlled with 5% (w/w) OptiPrep. The loaded gradient was
centrifuged in an SW 41 Ti rotor (Beckmann Coulter) at 100 000 × g for 6 h
at 4◦C. Early endosome fraction was collected with the peristaltic pump
from the 5–18% interphase.
Cross-linking of membrane-bound proteins
and immunoisolation of APPL-associated complexes
1,4-Di-(3 -[2 pyridyldithio]-propionamido) butane (DPDPB) was used for the
cross-linking of PNS or a gradient fraction enriched in early endosomes
(collected from the 5–18% interphase of a step Optiprep gradient). Four
hundred microliters of PNS adjusted to a ﬁnal volume of 1 mL with 5%
(w/v) OptiPrep or 1 mL of an OptiPrep gradient fraction enriched in early
endosomes was mixed with DPDPB to a ﬁnal concentration of 5 mM. After
30 min of incubation at 30◦C, excess of DPDPB was quenched with 50 mM
L-cystein for 45 min at 4◦C.
To prepare a resin with covalently bound antibodies, 80 μL of Protein
G Agarose (Roche) was equilibrated with 10 mM Tris–HCl pH 8.0 and
mixed with 4 μL of rabbit anti-APPL1 antibodies or unspeciﬁc rabbit
immunoglobulins. After 90 min of incubation at room temperature and a
brief centrifugation the resin was washed with 200 mM Na2B4O7 pH 9.0,
and incubated for 30 min with 20 mM dimethyl pimelimidate (DMP) cross-
linker in 200 mM Na2B4O7 pH 9.0. Afterwards the resin was washed with
200 mM ethanolamine pH 8.0 to quench the excess of DMP and incubated
with 200 mM ethanolamine pH 8.0 for 2 h at room temperature, followed
by a series of washes with PBS or PBS with 500 mM NaCl and ﬁnally
equilibrated with immunoisolation buffer [150 mM NaCl, 1 mM EGTA, 1 mM
ethylenediaminetetraacetic acid (EDTA), 1% Triton-X-100, 10% glycerol].
For immunoisolation, 80 μL of antibody-conjugated resin was mixed with
approximately220 μgofcross-linkedproteinsfromPNSorearlyendosome-
enriched gradient fractions, and incubated overnight at 4◦C, followed by a
series of 10 washes with the immunoisolation buffer. Proteins bound to
the resin were eluted with 100 mM glycine pH 2.5 at room temperature.
The eluates were mixed with Laemmli buffer and loaded on SDS–PAGE.
Silver-stained bands were analyzed by mass spectrometry at the Institute
of Biochemistry and Biophysics in Warsaw.
GST pull-down and in vitro binding assays
The full-length GST–Annexin A2 fusion protein, its mutant versions or GST
alone were expressed and puriﬁed according to the manufacturer’s instruc-
tions (GE Healthcare). Isopropyl-1-thio-β-d-galactopyranoside (Sigma) at a
concentration of 0.5 mM was used to induce protein expression. HEK293
cells transfected with pcDNA3-HA-APPL1 or pcDNA3-HA-APPL2 were
lysed in ice-cold pull-down buffer (150 mM NaCl, 50 mM HEPES pH 7.4,
1m M EDTA, 1 mMEGTA, 10% glycerol, 1% Triton-X-100 and protease
inhibitors). The puriﬁed GST–Annexin A2 or GST alone bound to the
glutathione-Sepharose 4B beads (GE Healthcare) were incubated overnight
at 4◦C with HEK293 lysates. After incubation, beads were washed with
the pull-down buffer. Bound proteins were eluted with 10 mM glutathione
in 50 mM Tris–HCl pH 8.0 for 15 min at 22◦C. Eluates were resuspended
in Laemmli buffer, resolved on SDS–PAGE and immunoblotted for the
proteins of interest.
Invitro translationwascarriedoutinaTNTcoupledreticulocytelysateusing
the Transcend Non-Radioactive Translation Detection System (Promega)
according to the manufacturer’s recommendations. In vitro translated
protein was incubated overnight at 4◦C with constant rotation with 11 μL
of glutathione-Sepharose 4B beads carrying bound GST or GST–Annexin
A2 fusion protein. After incubation beads were washed and eluted as
above.
In vivo biotinylation and afﬁnity puriﬁcation
of APPL-binding proteins
For biotin–streptavidin pull-down assays HEK293 cells were transfected
with the plasmid encoding bacterial biotin ligase (BirA) (43) and pBT-
GFP, pBT-APPL2 or pBT-mycAPPL1, respectively. Forty-eight hours post-
transfection, cells were lysed in a lysis buffer (150 mM KCl, 20 mM Tris–HCl
pH 8.0, 1% Triton-X-100, protease inhibitors). Cell lysates were centrifuged
at 20 800 × g for 15 min and the supernatants were incubated with
Dynabeads M-280 streptavidin (Dynal; Invitrogen) for 45 min. Beads were
separated by using a magnet (Dynal; Invitrogen) and washed ﬁve times
in a lysis buffer. For protein elution, the beads were boiled in Laemmli
buffer. Samples were resolved on 10% SDS–PAGE and immunoblotted
with anti-Annexin A2 antibody (BD Biosciences).
RNA interference
Three siRNA duplexes targeting human Annexin A2 (AnxA2 siRNA_1: 5 -
GCAAGUCCCUGUACUAUUAtt-3 ; AnxA2 siRNA_2: 5 -GAACUUGCAUCA
GCACUGAtt-3 ; AnxA2 siRNA_3: 5 -CCAGCUUGCGAAUAACAGUtt-3 ), as
well as two non-targeting negative control duplexes were obtained from
Ambion. CCD-1070SK cells were transfected in 24-well dishes with
Lipofectamine LTX (Invitrogen) according to the manufacturer’s protocols.
Analyses were performed 96 h after transfection.
Immunoﬂuorescence and quantitative image analysis
CCD-1070SK cells were plated on 12-mm coverslips in 24-well plates in
500 μL DMEM medium with 10% serum, and transfected if appropriate.
They were ﬁxed with 3% paraformaldehyde, permeabilized with 0.1%
(w/v) saponin and processed for immunoﬂuorescence with appropriate
primary and secondary antibodies. Alternatively, cells were permeabilized
with 0.1% Triton-X-100 prior to ﬁxation as described previously (67). For
quantitative analysis of APPL2 signal, at least 20 images (12 bit pixel depth)
per condition were taken using a confocal microscope (Leica TCS SP2 with
AOBS) with a 63×/1.4 numerical aperture (NA) oil immersion objective,
200 Hz speed and 1024 × 1024 pixel resolution. Images were exported
as TIFF ﬁles directly into the MOTIONTRACKING/KALAIMOSCOPE software
(www.kalaimoscope.com) (49,50).TwomorphometricparametersofAPPL
endosomes were calculated: (i) the total ﬂuorescence of a ﬂuorophore
(APPL2) detected in all vesicles, deﬁned as the total integral vesicle
intensity and expressed in arbitrary units (AU), and (ii) the number of
vesicles. Both parameters were calculated per masked area of each image.
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